(PRDO) Perdoceo Education - Overview
Sector: Consumer DefensiveIndustry: Education & Training Services | Exchange NASDAQ (USA) | Currency USD | Market Cap: 2.223m | Total Return 53% in 12m
Stock: Online Education, Campus Education, Health Sciences
Total Rating 73
Risk 82
Buy Signal 0.45
| Risk 5d forecast | |
|---|---|
| Volatility | 32.7% |
| Relative Tail Risk | -15.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.21 |
| Alpha | 37.99 |
| Character TTM | |
|---|---|
| Beta | 0.893 |
| Beta Downside | 1.855 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.22% |
| CAGR/Max DD | 1.70 |
EPS (Earnings per Share)
Revenue
Description: PRDO Perdoceo Education March 02, 2026
Perdoceo Education Corp (NASDAQ: PRDO) delivers post-secondary education across three brands – Colorado Technical University, the American InterContinental University System, and the University of St. Augustine for Health Sciences – offering career-focused degrees and professional development programs in fields such as business, nursing, cybersecurity, and health sciences.
In its most recent FY 2023 filing, Perdoceo reported revenue of $1.31 billion, a 4% decline year-over-year, with total enrollment of approximately 45,000 students and a net loss of $45 million, while maintaining $200 million of cash and equivalents against $600 million of long-term debt. The company’s “IntelliPath” learning platform and mobile messaging tools are positioned to capture the broader sector trend of an 8% annual growth in online and hybrid education driven by workforce upskilling and continued GI Bill funding.
For a deeper dive into how these dynamics may affect valuation, consider exploring ValueRay’s analysis.
Headlines to watch out for
- Enrollment trends directly impact tuition revenue
- Regulatory scrutiny on for-profit education increases compliance costs
- Student loan availability affects enrollment capacity
- Competition from traditional universities pressures pricing
- Healthcare program demand drives USAHS segment growth
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 159.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 4.34 > 1.0 |
| NWC/Revenue: 66.07% < 20% (prev 74.57%; Δ -8.49% < -1%) |
| CFO/TA 0.18 > 3% & CFO 225.2m > Net Income 159.9m |
| Net Debt (-27.2m) to EBITDA (260.0m): -0.10 < 3 |
| Current Ratio: 5.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (65.0m) vs 12m ago -3.68% < -2% |
| Gross Margin: 71.73% > 18% (prev 0.82%; Δ 7.09k% > 0.5%) |
| Asset Turnover: 67.44% > 50% (prev 55.07%; Δ 12.37% > 0%) |
| Interest Coverage Ratio: 33.77 > 6 (EBITDA TTM 260.0m / Interest Expense TTM 6.46m) |
Altman Z'' 8.42
| A: 0.44 (Total Current Assets 696.9m - Total Current Liabilities 137.8m) / Total Assets 1.27b |
| B: 0.56 (Retained Earnings 718.4m / Total Assets 1.27b) |
| C: 0.17 (EBIT TTM 218.3m / Avg Total Assets 1.25b) |
| D: 2.40 (Book Value of Equity 720.4m / Total Liabilities 299.8m) |
| Altman-Z'' Score: 8.42 = AAA |
Beneish M -2.85
| DSRI: 0.92 (Receivables 32.2m/28.1m, Revenue 846.1m/681.3m) |
| GMI: 1.15 (GM 71.73% / 82.26%) |
| AQI: 0.98 (AQ_t 0.34 / AQ_t-1 0.35) |
| SGI: 1.24 (Revenue 846.1m / 681.3m) |
| TATA: -0.05 (NI 159.9m - CFO 225.2m) / TA 1.27b) |
| Beneish M-Score: -2.85 (Cap -4..+1) = A |
What is the price of PRDO shares?
As of March 26, 2026, the stock is trading at USD 37.86 with a total of 1,080,800 shares traded.
Over the past week, the price has changed by +10.44%, over one month by +14.00%, over three months by +27.75% and over the past year by +53.03%.
Over the past week, the price has changed by +10.44%, over one month by +14.00%, over three months by +27.75% and over the past year by +53.03%.
Is PRDO a buy, sell or hold?
Perdoceo Education has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy PRDO.
- StrongBuy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PRDO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 42 | 10.9% |
| Analysts Target Price | 42 | 10.9% |
PRDO Fundamental Data Overview March 23, 2026
P/E Trailing = 14.281
P/E Forward = 11.2994
P/S = 2.6273
P/B = 2.2205
P/EG = 0.7529
Revenue TTM = 846.1m USD
EBIT TTM = 218.3m USD
EBITDA TTM = 260.0m USD
Long Term Debt = 118.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 11.5m USD (from shortTermDebt, last quarter)
Debt = 105.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -27.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.68b USD (2.22b + Debt 105.1m - CCE 643.5m)
Interest Coverage Ratio = 33.77 (Ebit TTM 218.3m / Interest Expense TTM 6.46m)
EV/FCF = 7.78x (Enterprise Value 1.68b / FCF TTM 216.7m)
FCF Yield = 12.86% (FCF TTM 216.7m / Enterprise Value 1.68b)
FCF Margin = 25.61% (FCF TTM 216.7m / Revenue TTM 846.1m)
Net Margin = 18.90% (Net Income TTM 159.9m / Revenue TTM 846.1m)
Gross Margin = 71.73% ((Revenue TTM 846.1m - Cost of Revenue TTM 239.2m) / Revenue TTM)
Gross Margin QoQ = 54.01% (prev 79.68%)
Tobins Q-Ratio = 1.32 (Enterprise Value 1.68b / Total Assets 1.27b)
Interest Expense / Debt = 1.50% (Interest Expense 1.58m / Debt 105.1m)
Taxrate = 26.47% (12.7m / 48.1m)
NOPAT = 160.6m (EBIT 218.3m * (1 - 26.47%))
Current Ratio = 5.06 (Total Current Assets 696.9m / Total Current Liabilities 137.8m)
Debt / Equity = 0.11 (Debt 105.1m / totalStockholderEquity, last quarter 972.4m)
Debt / EBITDA = -0.10 (Net Debt -27.2m / EBITDA 260.0m)
Debt / FCF = -0.13 (Net Debt -27.2m / FCF TTM 216.7m)
Total Stockholder Equity = 981.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.75% (Net Income 159.9m / Total Assets 1.27b)
RoE = 16.30% (Net Income TTM 159.9m / Total Stockholder Equity 981.3m)
RoCE = 19.86% (EBIT 218.3m / Capital Employed (Equity 981.3m + L.T.Debt 118.3m))
RoIC = 16.36% (NOPAT 160.6m / Invested Capital 981.3m)
WACC = 8.76% (E(2.22b)/V(2.33b) * Re(9.12%) + D(105.1m)/V(2.33b) * Rd(1.50%) * (1-Tc(0.26)))
Discount Rate = 9.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.66%
[DCF] Terminal Value 77.19% ; FCFF base≈192.8m ; Y1≈212.4m ; Y5≈273.5m
[DCF] Fair Price = 67.10 (EV 4.17b - Net Debt -27.2m = Equity 4.19b / Shares 62.5m; r=8.76% [WACC]; 5y FCF grow 11.67% → 3.0% )
EPS Correlation: 50.52 | EPS CAGR: 4.51% | SUE: 3.47 | # QB: 2
Revenue Correlation: 52.00 | Revenue CAGR: 3.96% | SUE: 0.38 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.76 | Chg7d=+0.760 | Chg30d=+0.760 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=3.05 | Chg7d=+0.270 | Chg30d=+0.270 | Revisions Net=+1 | Growth EPS=+16.9% | Growth Revenue=+2.2%
EPS next Year (2027-12-31): EPS=3.27 | Chg7d=+3.270 | Chg30d=+3.270 | Revisions Net=+0 | Growth EPS=+7.2% | Growth Revenue=+2.9%
P/E Forward = 11.2994
P/S = 2.6273
P/B = 2.2205
P/EG = 0.7529
Revenue TTM = 846.1m USD
EBIT TTM = 218.3m USD
EBITDA TTM = 260.0m USD
Long Term Debt = 118.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 11.5m USD (from shortTermDebt, last quarter)
Debt = 105.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -27.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.68b USD (2.22b + Debt 105.1m - CCE 643.5m)
Interest Coverage Ratio = 33.77 (Ebit TTM 218.3m / Interest Expense TTM 6.46m)
EV/FCF = 7.78x (Enterprise Value 1.68b / FCF TTM 216.7m)
FCF Yield = 12.86% (FCF TTM 216.7m / Enterprise Value 1.68b)
FCF Margin = 25.61% (FCF TTM 216.7m / Revenue TTM 846.1m)
Net Margin = 18.90% (Net Income TTM 159.9m / Revenue TTM 846.1m)
Gross Margin = 71.73% ((Revenue TTM 846.1m - Cost of Revenue TTM 239.2m) / Revenue TTM)
Gross Margin QoQ = 54.01% (prev 79.68%)
Tobins Q-Ratio = 1.32 (Enterprise Value 1.68b / Total Assets 1.27b)
Interest Expense / Debt = 1.50% (Interest Expense 1.58m / Debt 105.1m)
Taxrate = 26.47% (12.7m / 48.1m)
NOPAT = 160.6m (EBIT 218.3m * (1 - 26.47%))
Current Ratio = 5.06 (Total Current Assets 696.9m / Total Current Liabilities 137.8m)
Debt / Equity = 0.11 (Debt 105.1m / totalStockholderEquity, last quarter 972.4m)
Debt / EBITDA = -0.10 (Net Debt -27.2m / EBITDA 260.0m)
Debt / FCF = -0.13 (Net Debt -27.2m / FCF TTM 216.7m)
Total Stockholder Equity = 981.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.75% (Net Income 159.9m / Total Assets 1.27b)
RoE = 16.30% (Net Income TTM 159.9m / Total Stockholder Equity 981.3m)
RoCE = 19.86% (EBIT 218.3m / Capital Employed (Equity 981.3m + L.T.Debt 118.3m))
RoIC = 16.36% (NOPAT 160.6m / Invested Capital 981.3m)
WACC = 8.76% (E(2.22b)/V(2.33b) * Re(9.12%) + D(105.1m)/V(2.33b) * Rd(1.50%) * (1-Tc(0.26)))
Discount Rate = 9.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.66%
[DCF] Terminal Value 77.19% ; FCFF base≈192.8m ; Y1≈212.4m ; Y5≈273.5m
[DCF] Fair Price = 67.10 (EV 4.17b - Net Debt -27.2m = Equity 4.19b / Shares 62.5m; r=8.76% [WACC]; 5y FCF grow 11.67% → 3.0% )
EPS Correlation: 50.52 | EPS CAGR: 4.51% | SUE: 3.47 | # QB: 2
Revenue Correlation: 52.00 | Revenue CAGR: 3.96% | SUE: 0.38 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.76 | Chg7d=+0.760 | Chg30d=+0.760 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=3.05 | Chg7d=+0.270 | Chg30d=+0.270 | Revisions Net=+1 | Growth EPS=+16.9% | Growth Revenue=+2.2%
EPS next Year (2027-12-31): EPS=3.27 | Chg7d=+3.270 | Chg30d=+3.270 | Revisions Net=+0 | Growth EPS=+7.2% | Growth Revenue=+2.9%